← Open Payments lookup

MARK SMITH: Open Payments

NPI 1063432284 · GAITHERSBURG, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$899 in 63 payments from 10 companies in 2025. Trend: 2023 $1,286 · 2024 $1,458 · 2025 $899

Food & beverage: $899
CompanyPaymentsAmount
Lundbeck LLC10$184
ABBVIE INC.13$182
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$173
Otsuka America Pharmaceutical, Inc.12$147
Vanda Pharmaceuticals Inc.4$72
Takeda Pharmaceuticals U.S.A., Inc.2$45
Collegium Pharmaceutical, Inc.2$34
Lilly USA, LLC1$27
Vertical Pharmaceuticals, LLC1$21
Axsome Therapeutics, Inc.1$15

Products named: REXULTI, CAPLYTA, VRAYLAR, FANAPT, ABILIFY ASIMTUFII, TRINTELLIX, Jornay PM, ABILIFY MAINTENA.

Industry payments across MD — which companies pay providers there.